Multidisciplinary Association For Psychedelic Studies, Inc.

Federal agencies discussed new PTSD treatments, including psychedelics like MDMA and ketamine, acknowledging their potential but stressing the need for further research. The Reagan-Udall Foundation meeting highlighted growing public interest in psychedelic-assisted therapies, with stakeholders largely supporting wider access. Despite FDA's recent denial of MDMA-assisted therapy approval, there is bipartisan support and ongoing research initiatives, particularly within the VA, to explore these treatments further.